ANIP compared with KNSA: revenue, margins and what each company keeps, and the suppliers and customers both name

ANIPANI Pharmaceuticals Inc

Mkt capRevenueRevenue

KNSAKiniksa Pharmaceuticals International, plc

Mkt capRevenueRevenue

Compare

ANIPANI Pharmaceuticals Inc

KNSAKiniksa Pharmaceuticals International, plc

Price

Mkt cap

Revenue

Co-movers

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

daily closesMethod ›

Moved together

ANIPwithKNSA

No shared trading history for ANIP and KNSA.

Shared co-movers: not yet measured (KNSA).

ANIP, solidKNSA, hatchedr = correlationBar = r to r 0.75Source: daily closes

ANIPANI Pharmaceuticals Inc

67.43▼−3.14%· post 67.44

Mkt cap$1.6BRevenue$291MQ3 FY26Revenue$883MFY25

KNSAKiniksa Pharmaceuticals International, plc

93.80▲+6.18%· post 94.50

ClosedNov 6 '26

Mkt cap$7.4BRevenue$286MQ3 FY26Revenue$678MFY25

Compare

ClosedNov 6 '26

ANIPANI Pharmaceuticals Inc

KNSAKiniksa Pharmaceuticals International, plc

67.43▼−3.14%post 67.44

Price

93.80▲+6.18%post 94.50

$1.6B

Mkt cap

$7.4B

Q3 FY26$291M

Revenue

$286MQ3 FY26

FY25$883M

Revenue

$678MFY25

ANIP67.43▼−3.14%vsKNSA93.80▲+6.18%ClosedNov 6 '26